Targeted
construction of therapeutic nanoplatforms in
tumor cells
with specific activation remains appealing but challenging. Here,
we design a cancer-motivated upconversion nanomachine (UCNM) based
on porous upconversion nanoparticles (p-UCNPs) for precise phototherapy.
The nanosystem is equipped with a telomerase substrate (TS) primer
and simultaneously encapsulates 5-aminolevulinic acid (5-ALA) and d-arginine (d-Arg). After coating with hyaluronic acid
(HA), it can readily get into tumor cells, where 5-ALA induces efficient
accumulation of protoporphyrin IX (PpIX) via the inherent biosynthetic
pathway, and the overexpressed telomerase prolonged the TS to form
G-quadruplexes (G4) for binding the resulting PpIX as a nanomachine.
This nanomachine can respond to near-infrared (NIR) light and promote
the active singlet oxygen (1O2) production due
to the efficiency of Förster resonance energy transfer (FRET)
between p-UCNPs and PpIX. Intriguingly, such oxidative stress can
oxidize d-Arg into nitric oxide (NO), which relieves the
tumor hypoxia and in turn improves the phototherapy effect. This in situ assembly approach significantly enhances targeting
in cancer therapy and might be of considerable clinical value.